KBLB - Kraig Biocraft Laboratories, Inc.

Other OTC - Other OTC Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
176.431
176.431
197.745
88.47
223.05
Selling general and administrative
1,945
1,945
2,562
4,446
2,399
Total operating expenses
2,121
2,121
2,760
4,534
2,622
Operating income or loss
-2,121
-2,121
-2,760
-4,534
-2,622
Interest expense
314.107
609.129
660.419
386.624
294.352
Total other income/expenses net
0.038
0.038
77.096
-
-
Income before tax
-3,842
-3,842
-8,046
-4,971
-2,910
Income tax expense
0
0
0
0
0
Income from continuing operations
-3,842
-3,842
-8,046
-4,971
-2,910
Net income
-3,842
-3,842
-8,046
-4,971
-2,910
Net income available to common shareholders
-3,842
-3,842
-8,046
-4,971
-2,910
Basic EPS
-
-
-0.01
-0.01
-0.00
Diluted EPS
-
-
-0.01
-0.01
-0.00
Basic average shares
-
-
877,612
848,651
835,587
Diluted average shares
-
-
877,612
848,651
835,587
EBITDA
-
-3,205
-7,359
-4,557
-2,585